We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, a... Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. Show more
The major U.S. index futures are currently pointing to roughly flat open on Tuesday, with stocks likely to show a lack of direction after ending yesterdayβs lackluster session modestly higher...
U.S. index futures indicate a slightly lower opening for Tuesday’s trading as Wall Street positions itself for a series of significant earnings releases from large-cap companies. This...
HSBC (NYSE:HSBC) – Shares of HSBC advanced 3.7% in pre-market trading after revealing its first quarter results. With revenue of $20.8 billion, a 3% increase from the previous year, the...
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum PR Newswire INDIANAPOLIS, April 30, 2024 Revenue in Q1 2024...
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity PR Newswire INDIANAPOLIS, April 17, 2024 Tirzepatide achieved a mean...
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement PR Newswire INDIANAPOLIS, April 16, 2024 INDIANAPOLIS, April 16, 2024 /PRNewswire/ -- Eli Lilly and...
Taiwan Semiconductor Manufacturing Company (NYSE:TSM) – TSMC evacuated some factories and suspended operations after a 7.4 magnitude earthquake hit Taiwan, raising concerns about the global...
More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study PR Newswire INDIANAPOLIS, March 10, 2024...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.03 | -0.139945652174 | 736 | 795.4975 | 729.61 | 4161136 | 760.64431179 | CS |
4 | -50.03 | -6.37324840764 | 785 | 795.4975 | 718.3 | 2752819 | 750.74548727 | CS |
12 | -5.83 | -0.786987041037 | 740.8 | 800.78 | 718.3 | 2911855 | 760.81378172 | CS |
26 | 163.87 | 28.6937489056 | 571.1 | 800.78 | 561.65 | 3119980 | 681.55334745 | CS |
52 | 306.56 | 71.5576200369 | 428.41 | 800.78 | 419.8 | 3012548 | 598.31622434 | CS |
156 | 543.18 | 283.216017519 | 191.79 | 800.78 | 189.3227 | 2993692 | 394.6485023 | CS |
260 | 619.15 | 534.579519945 | 115.82 | 800.78 | 101.36 | 3325980 | 279.4251311 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions